B01J31/182

CHIRAL LIGAND-BASED METAL-ORGANIC FRAMEWORKS FOR BROAD-SCOPE ASYMMETRIC CATALYSIS
20170173572 · 2017-06-22 ·

Metal-organic framework (MOFs) compositions based on chiral phosphine-, chiral oxazoline-, chiral pyridine-, and chiral diene-derived organic bridging ligands were synthesized and then post-synthetically metalated with metal precursors such as Ru and Rh complexes. The metal complexes could also be directly incorporated into the MOFs. The MOFs provide a versatile family of recyclable and reusable single-site solid catalysts for catalyzing a variety of asymmetric organic transformations, including the addition of arylboronic acids to ,-unsaturated ketones and alkimines, the hydrogenation of substituted alkene and carbonyl compounds, and cyclization reactions. The solid catalysts can also be integrated into a flow reactor or a supercritical fluid reactor.

Zinc complex

A zinc complex characterized in exhibiting an octahedral structure and being configured from repeating units represented by general formula (I): ##STR00001##
wherein L represents a linker region, and R.sup.1 represents a C1-4 alkyl group, which can have a halogen atom.

CHIRAL SPIROCYCLIC COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF

Spirocyclic compounds, including chiral spiro diamine, chiral spiro amino naphthol, chiral spiro bis(indole), chiral spiro diaryl diol, chiral spiro diaryl diamine, chiral spiro amino naphthol, chiral spiro diaryl diindole, and chiral spiro phospholane useful as chiral ligands and chiral organocatalysts and methods of preparation and methods of use thereof. Owing to the molecular shape and three-dimensional orientation, the chiral diamine and chiral amino naphthol molecules provide a skeleton for use as ligands and organocatalysts.

A 6-substituted Chiral Pure Difluoropiperidine Quinazoline Derivative And Its Preparation Method
20250092015 · 2025-03-20 ·

The present disclosure discloses a preparation method for 6-substituted chiral pure difluoropiperidine quinazoline derivative, in particular the 6-substituted chiral pure difluoropiperidine quinazoline derivative shown in Formula (I).

##STR00001##

The preparation method provided by the present disclosure is characterized by high chiral selectivity, high yield, and good process stability, which is of great significance for further production scale-up and commercialization of said solid drugs.

PROCESS FOR UNPROTECTED ASYMMETRIC PREPARATION OF NICOTINE

The present disclosure relates to an asymmetric process for preparing nicotine without protection, in particular to a process for preparing optically pure nicotine by taking nicotinate as a starting material and carrying out four-step reaction. The process comprises the following steps: nicotinate and -butyrolactone are subjected to condensation reaction, asymmetric catalytic reduction reaction, activation, and reaction with methylamine to give optically pure nicotine. The asymmetric catalytic reduction for preparing the chiral alcohol intermediate compound with high optical activity is a key step of the method. The method of the present disclosure has the characteristics of high atom economy, very high reaction activity, capability of keeping excellent stereocontrol, capability of obtaining a chiral product with very high enantioselectivity, short reaction steps, low cost of raw materials, green and pollution-free, capability of greatly reducing the quantity of three wastes, and easiness in realizing industrial amplification production.

Palladium(II) complex for catalyzing sonogashira coupling reactions and a method thereof

A palladium(II) complex which catalyzes the Sonogashira coupling reaction efficiently under aerobic condition and a method of employing the palladium(II) complex to synthesize internal alkynes. The palladium(II) complex is an effective catalyst for the coupling reactions of aryl iodo and diiodo compounds with unactivated alkyl alkynes and terminal dialkynes to produce various novel symmetrical dialkynes and disubstituted internal alkynes in excellent yields.

Borylimide catalysts

The present invention provides a borylimide catalyst and further relates to compositions comprising the borylimide catalysts and processes for the polymerisation of olefins (e.g. ethylene) using the borylimide catalysts or the compositions comprising the borylimide catalysts.

Air-stable ni(0)-olefin complexes and their use as catalysts or precatalysts

The present invention relates to air stable, binary Ni(0)-olefin complexes and their use in organic synthesis.

Diphenylamine-linked chiral bis(oxazoline) ligand without C.SUB.2.-symmetry, synthesis method and application thereof

The present invention discloses a diphenylamine-linked chiral bis(oxazoline) ligand without C.sub.2-symmetry of formula 3 and its synthesis method and application in an asymmetric catalytic reaction, wherein C.sub.2-symmetry is lost by introducing different groups into the diphenylamine backbone to realize precise control of electronic effect of the ligand backbone. An anthranilic acid derivative and an orthochlorobenzoic acid derivative are used as starting materials to prepare a compound of formula 1, and then the compound of formula 1 is reacted with a chiral amino alcohol compound to prepare a -bishydroxy amide compound of formula 2, and the compound of formula 2 is further subjected to condensation to obtain the diphenylamine-linked chiral bis(oxazoline) ligand without C.sub.2-symmetry of formula 3. The present invention also provides an application of a catalyst formed by coordination of the diphenylamine-linked chiral bis(oxazoline) ligand without C.sub.2-symmetry with copper salt, zinc salt, nickel salt, iron salt or rhodium salt, in an asymmetric catalytic reaction. ##STR00001##

Degradative method

The present invention relates to a method of degrading biofilm by contacting it with an aqueous mixture comprising a peroxide compound and a manganese complex, wherein the aqueous mixture comprises a macrocylic ligand. The invention also relates to a method of degrading a biofilm by contacting it with an aqueous mixture comprising a peroxide compound and a macrocyclic ligand.